The FDA has published its yearly list of new, withdrawn and revised CDER guidances. This list provides a very good overview about the agency’s activities regarding these documents. Guidance documents represent the Agency's current thinking on a particular subject and are an important part to define cGMP. Nevertheless, an alternative approach may be used if such approach satisfies the requirements of the applicable statute, regulations, or both.
On the behalf of the European Compliance Academy (ECA)